(Press-News.org) This news release is available in German.
Bio-engineers are working on the development of biological computers with the aim of designing small circuits made from biological material that can be integrated into cells to change their functions. In the future, such developments could enable cancer cells to be reprogrammed, thereby preventing them from dividing at an uncontrollable rate. Stem cells could likewise be reprogrammed into differentiated organ cells.
The researchers have not progressed that far yet. Although they have spent the past 20 years developing individual components and prototypes of biological computers, bio-computers today still differ significantly from their counterparts made of silicon, and bio-engineers still face several major obstacles.
A silicon chip, for example, computes with ones and zeros – current is either flowing or not – and it can switch between these states in the blink of an eye. In contrast, biological signals are less clear: in addition to 'signal' and 'no signal', there is a plethora of intermediate states with 'a little bit of signal'. This is a particular disadvantage for bio-computer components that serve as sensors for specific biomolecules and transmit the relevant signal. Sometimes, they also send an output signal if no input signal is present, and the problem becomes worse when several such components are connected consecutively in a circuit.
A biosensor that does not 'leak'
ETH doctoral candidate Nicolas Lapique from the group led by Yaakov Benenson, Professor of Synthetic Biology in the Department of Biosystems Science and Engineering at ETH Zurich in Basel, has now developed a biological circuit that controls the activity of individual sensor components using internal "timer". This circuit prevents a sensor from being active when not required by the system; when required, it can be activated via a control signal. The researchers recently published their work in the scientific journal Nature Chemical Biology.
To understand the underlying technology, it is important to know that these biological sensors consist of synthetic genes that are read by enzymes and converted into RNA and proteins. In the controllable biosensor developed by Lapique, the gene responsible for the output signal is not active in its basic state, as it is installed in the wrong orientation in the circuit DNA. The gene is activated via a special enzyme, a recombinase, which extracts the gene from the circuit DNA and reinstalls it in the correct orientation, making it active. "The input signals can be transmitted much more accurately than before thanks to the precise control over timing in the circuit," says Benenson.
To date, the researchers have tested the function of their activation-ready sensor in cell culture of human kidney and cancer cells. Nevertheless, they are already looking ahead to further developing the sensor so that it can be used in a more complex bio-computer that detects and kills cancer cells. These bio-computers will be designed to detect typical cancer molecules. If cancer markers are found in a cell, the circuit could, for example, activate a cellular suicide programme. Healthy cells without cancer markers would remain unaffected by this process.
Versatile signal converter developed
Still, combining various biological components to form more complex bio-computers constitutes a further challenge for bio-engineers. "In electronics, the different components that make up a circuit are always connected in the same way: with a wire through which the current either flows or not," explains Benenson. In biology, there are a variety of different signals – a host of different proteins or microRNA molecules. In order to combine biologic components in any desired sequence signal converters must be connected between them.
Laura Prochazka, also a doctoral candidate student under Benenson, has developed a versatile signal converter. She published her work recently in the magazine Nature Communications. A special feature of the new component is that not only it converts one signal into another, but it can also be used to convert multiple input signals into multiple output signals in a straightforward manner.
This new biological platform will significantly increase the number of applications for biological circuits. As Benenson says, "The ability to combine biological components at will in a modular, plug-and-play fashion means that we now approach the stage when the concept of programming as we know it from software engineering can be applied to biological computers. Bio-engineers will literally be able to program in future."
INFORMATION:
Literature reference
Lapique N, Benenson Y: Digital switching in a biosensor circuit via programmable timing of gene availability. Nature Chemical Biology, online publication 14 October 2014, doi: 10.1038/nchembio.1680
Prochazka L, Angelici B, Häfliger B, Benenson Y: Highly modular bow-tie gene circuits with programmable dynamic behavior, Nature Communications, online publication 14 October 2014, doi: 10.1038/ncomms5729
Scientists at the University of Manchester, King's College London and the University of Liverpool have found that an infant's preference for a person's face, rather than an object, is associated with lower levels of callous and unemotional behaviors in toddlerhood.
The study, which was published in Biological Psychiatry, assessed if 213 five-week-old infants spent longer tracking a person's face compared to an inanimate object – in this case a red ball.
The researchers showed that greater tracking of the face relative to the ball was linked to lower callous unemotional ...
This news release is available in Spanish.
Martín Olazar, a UPV/EHU chemical engineer, has designed a fundamental process for producing alternatives to petroleum in sustainable refineries. As Olazar himself pointed out, one of the unavoidable conditions of the process is not to harm the environment. This researcher has developed a reactor based on conical spouted beds which, by means of flash or rapid pyrolysis, produces fuels and raw materials using various types of waste.
Olazar has developed two lines, depending on the type of waste: one uses biomass; the ...
The average U.S. doctor spends 16.6 percent of his or her working hours on non-patient-related paperwork, time that might otherwise be spent caring for patients. And the more time doctors spend on such bureaucratic tasks, the unhappier they are about having chosen medicine as a career.
These are some of the findings of a nationwide study by Drs. Steffie Woolhandler and David Himmelstein, internists in the South Bronx who serve as professors of public health at the City University of New York and lecturers in medicine at Harvard Medical School. The study was published ...
MANHATTAN, Kansas — Football teams are claiming it improves their athletic performance, and according to new research from Kansas State University, it also benefits heart failure patients. The special ingredient: beetroot.
Recently, the Auburn University football team revealed its pregame ritual of taking beetroot concentrate, or beet juice, before each game. The juice may have contributed to the team's recent winning season — and one exercise physiologist who has been studying the supplement for several years says that may be the case.
"Our research, published ...
Scientists have identified 181 California dams that may need to increase water flows to protect native fish downstream. The screening tool developed by the Center for Watershed Sciences at the University of California, Davis, to select "high-priority" dams may be particularly useful during drought years amid competing demands for water.
"It is unpopular in many circles to talk about providing more water for fish during this drought, but to the extent we care about not driving native fish to extinction, we need a strategy to keep our rivers flowing below dams," said lead ...
Future prevention and treatment strategies for vascular diseases may lie in the evaluation of early brain imaging tests long before heart attacks or strokes occur, according to a systematic review conducted by a team of cardiologists, neuroscientists, and psychiatrists from Icahn School of Medicine at Mount Sinai and published in the October issue of JACC Cardiovascular Imaging.
For the review, Mount Sinai researchers examined all relevant brain imaging studies conducted over the last 33 years. They looked at studies that used every available brain imaging modality in ...
No-till farming, a key conservation agriculture strategy that avoids conventional plowing and otherwise disturbing the soil, may not bring a hoped-for boost in crop yields in much of the world, according to an extensive new meta-analysis by an international team led by the University of California, Davis.
As the core principle of conservation agriculture, no-till has been promoted worldwide in an effort to sustainably meet global food demand. But after examining results from 610 peer-reviewed studies, the researchers found that no-till often leads to yield declines compared ...
University of Southampton scientists have designed a new experiment to test the foundations of quantum mechanics at the large scale.
Standard quantum theory places no limit on particle size and current experiments use larger and larger particles, which exhibit wave-like behaviour. However, at these masses experiments begin to probe extensions to standard quantum mechanics, which describe the apparent quantum-to-classical transition.
Now, Southampton researchers, with colleagues from the University of Duisburg-Essen in Germany, have designed a new type of experiment ...
Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether the drug offers an added benefit over the appropriate comparator therapy in these patient groups. According to the findings, such an added benefit is not proven because the dossier contained no suitable data for any of the two ...
On behalf of the Federal Ministry of Health (BMG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether specific methodological aspects have to be considered in the conduct, analysis and assessment of the certainty of results of studies on rare diseases. Within the framework of the same commission, the Institute also analysed the underlying studies for the approval of so-called orphan drugs, i.e. drugs for rare diseases, in Europe.
The result: For a different approach than in more common diseases, there are neither scientific reasons ...
